| HOME >> BIOLOGY >> TECHNOLOGY |
allowance for doubtful accounts of
$57,954 and $55,640 as of March 31,
2008 and December 31, 2007,
respectively 13,212,089 13,626,347
Notes receivables 1,682,184 -
Inventories 4,923,381 3,948,460
Advances to suppliers 6,908,467 5,983,277
Other current assets 166,236 81,221
Total current assets 32,069,418 29,407,079
EQUIPMENT, net 1,352,430 1,388,919
OTHER ASSETS
Deferred expenses 618,131 678,237
Intangible assets, net 1,214,460 1,166,003
Total other assets 1,832,591 1,844,240
Total assets $ 35,254,439 $ 32,640,238
LIABILITIES AND SHAREHOLDERS' EQUITY
CURRENT LIABILITIES
Accounts payable, trade $48,664 $76,907
Other payables and accrued liabilities 21,497 70,343
Customer deposits 156,052 203,281
Taxes payable 342,019 468,184
Liquidated damages payable 44,003 44,003
Total liabilities 612,235 862,718
MINORITY INTEREST 866,385 893,337
SHAREHOLDERS' EQUITY
Preferred stock, $0.0001 par value;
10,000,000 shares authorized,
60,000 and 111,649 shares issued
and outstanding at March 31, 2008
and December 31 2007, respectively 6 11
Common stock, $0.0001 par value;
100,000,000 shares au
'/>"/>
| SOURCE China Medicine Corporation Copyright©2008 PR Newswire. All rights reserved |